Early prediction of neonatal chronic lung disease: a comparison of three scoring methods

B A Yoder1, M U Anwar, R H Clark

  • 1Department of Pediatrics, Wilford Hall Medical Center, Lackland Air Force Base, San Antonio, Texas 52636-02, USA. yoder_b@whmc-lafb.af.mil

Pediatric Pulmonology
|June 24, 1999
PubMed

Insights

A new Respiratory Failure Score (RFS) accurately predicts neonatal chronic lung disease (CLD) in high-risk infants. This simple method improves early patient selection for clinical trials investigating CLD prevention therapies.

Area of Science:

  • Neonatology
  • Pediatric Pulmonology
  • Clinical Trial Design

Background:

  • Neonatal chronic lung disease (CLD) poses significant challenges, necessitating effective early identification of high-risk infants for intervention trials.
  • Existing predictive models for CLD, such as the Sinkin and Ryan models, require validation in diverse populations.
  • Optimizing patient selection is crucial for the success of clinical trials evaluating postnatal therapies for CLD.

Purpose of the Study:

  • To develop and validate a simple clinical scoring system, the Respiratory Failure Score (RFS), for early prediction of neonatal CLD.
  • To compare the predictive performance of the RFS with established Sinkin and Ryan models in distinct infant populations.
  • To enhance the efficiency of clinical trials by improving the selection of high-risk infants for early intervention.

Main Methods:

  • A prospective cohort study was conducted involving infants born at <32 weeks gestation.
  • A Respiratory Failure Score (RFS) was developed using logistic regression, identifying gestation, birth weight, and RFS as key predictors.
  • The RFS, Sinkin, and Ryan models were retrospectively and prospectively compared using receiver operating characteristic (ROC) curves in multiple study groups.

Main Results:

  • The RFS, incorporating gestation and birth weight, demonstrated strong predictive capability for neonatal CLD.
  • All evaluated models (RFS, Sinkin, Ryan) showed similar performance across different study populations.
  • The RFS, assessed at 72 hours of age, exhibited the largest area under the ROC curve, indicating superior predictive accuracy for CLD at 36 weeks postconceptional age.

Conclusions:

  • The RFS is a reliable and simple method for the early prediction of neonatal CLD in preterm infants.
  • Implementing the RFS can significantly improve the selection of infants for early prevention trials, thereby optimizing research outcomes.
  • This validated scoring system offers a valuable tool for clinicians and researchers focused on mitigating the impact of CLD.

Related Concept Videos